Sugi Predict

Sugi Predict / Compounds / SCHEMBL4761650

SCHEMBL4761650

SCHEMBL4761650

CCOC(=O)c1coc(-c2ccc3c(c2)C(C)(C)[C@H]2COc4cccc(OC)c4[C@H]2N3)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.36
▸ MAPT P10636 3/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ CASP8 Q14790 1/20 0.33
▸ PDE4B Q07343 2/20 0.33
▸ NR3C1 P04150 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ HDAC1 Q13547 2/20 0.32
▸ HDAC8 Q9BY41 2/20 0.32
▸ HDAC6 Q9UBN7 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ HTT P42858 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ROCK2 O75116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4892482 0.85 MAPT (0.41) MAPTTP53PDE4BNR3C1PGR
SCHEMBL4896422 0.85 MAPT (0.41) MAPTTP53PDE4BNR3C1PGR
SCHEMBL4556010 0.85 TLR9 (0.34) APLNRPDE4BALDH1A1
SCHEMBL4813071 0.79 HDAC1 (0.33) PDE4BPGRHDAC1HDAC8HDAC6
SCHEMBL4628879 0.79 MAPT (0.36) MAPTTP53NR3C1PGRNPC1
SCHEMBL4890545 0.78 PDK2 (0.37) PGRNPC1RAB9AMEN1KMT2A
SCHEMBL4437149 0.78 HDAC1 (0.34) PDE4BHDAC1HDAC8HDAC6ROCK2
SCHEMBL4566784 0.78 RARA (0.43) PDE4BPGRMEN1KMT2APDE4D
SCHEMBL4611655 0.77 GUCY1A1 (0.37) MAPTTP53RAB9AHTTMEN1
SCHEMBL4864334 0.77 ADRA1D (0.35) NR3C1PGRROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293757-A1 ABCA1 ELEVATING COMPOUNDS ABELMAN MATTHEW 2008-11-27 — — US disclosed
US-7432276-B2 ABCA1 elevating compounds CV THERAPEUTICS, INC. (US) 2008-10-07 — — US disclosed
US-7423045-B2 ABCA1 elevating compounds CV THERAPEUTICS, INC. (US) 2008-09-09 — — US disclosed
EP-1907395-A1 ABCA1 ELEVATING COMPOUNDS CV THERAPEUTICS, INC. (US) 2008-04-09 — — EP disclosed
US-20070191379-A1 ABCA1 elevating compounds CV THERAPEUTICS, INC. 2007-08-16 — — US disclosed
US-20070010544-A1 ABCA1 elevating compounds CV THERAPEUTICS, INC. 2007-01-11 — — US disclosed
WO-2007002867-A1 ABCA1 ELEVATING COMPOUNDS CV THERAPEUTICS, INC. (US) 2007-01-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191379-A1 ABCA1 elevating compounds ABCD3, ABCB4, CETP APLNR 1123/4885NR1H4 86/4885MAPT 4361/4885
US-20080293757-A1 ABCA1 ELEVATING COMPOUNDS ABCD3, ABCB4, CETP APLNR 1123/4885NR1H4 86/4885MAPT 4361/4885
US-20070010544-A1 ABCA1 elevating compounds ABCD3, ABCB4, CETP APLNR 1123/4885NR1H4 86/4885MAPT 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.